These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Symptomatic treatment and management of multiple sclerosis. Toosy A; Ciccarelli O; Thompson A Handb Clin Neurol; 2014; 122():513-62. PubMed ID: 24507534 [TBL] [Abstract][Full Text] [Related]
8. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. Gustavsen S; Olsson A; Søndergaard HB; Andresen SR; Sørensen PS; Sellebjerg F; Oturai A BMC Neurol; 2021 Aug; 21(1):317. PubMed ID: 34399707 [TBL] [Abstract][Full Text] [Related]
10. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970 [TBL] [Abstract][Full Text] [Related]
11. [What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity]. Henze T; Feneberg W; Flachenecker P; Seidel D; Albrecht H; Starck M; Meuth SG Nervenarzt; 2017 Dec; 88(12):1428-1434. PubMed ID: 29063259 [TBL] [Abstract][Full Text] [Related]
12. Sexual dysfunction levels in iranian women suffering from multiple sclerosis. Dehghan-Nayeri N; Khakbazan Z; Ghafoori F; Nabavi SM Mult Scler Relat Disord; 2017 Feb; 12():49-53. PubMed ID: 28283107 [TBL] [Abstract][Full Text] [Related]
13. [The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis]. Korzhova JE; Chervyakov AV; Poydasheva AG; Kochergin IA; Peresedova AV; Zakharova MN; Suponeva NA; Chernikova LA; Piradov MA Vopr Kurortol Fizioter Lech Fiz Kult; 2016; 93(5):8-13. PubMed ID: 27801405 [TBL] [Abstract][Full Text] [Related]
14. Spasticity, ataxia and fatigue in multiple sclerosis. Kesselring J; Thompson AJ Baillieres Clin Neurol; 1997 Oct; 6(3):429-45. PubMed ID: 10101582 [TBL] [Abstract][Full Text] [Related]
15. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis. Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999 [TBL] [Abstract][Full Text] [Related]
16. Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis. Hameau S; Zory R; Latrille C; Roche N; Bensmail D Eur J Phys Rehabil Med; 2017 Dec; 53(6):833-840. PubMed ID: 27164538 [TBL] [Abstract][Full Text] [Related]
17. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Schmidt S; Jöstingmeyer P Mult Scler Relat Disord; 2019 Oct; 35():262-269. PubMed ID: 31437741 [TBL] [Abstract][Full Text] [Related]
18. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis. Wang G; Marrie RA; Fox RJ; Tyry T; Cofield SS; Cutter GR; Salter A Mult Scler Relat Disord; 2018 Feb; 20():16-21. PubMed ID: 29275057 [TBL] [Abstract][Full Text] [Related]
19. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors. Krause I; Kern S; Horntrich A; Ziemssen T Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910 [TBL] [Abstract][Full Text] [Related]
20. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V; Mult Scler Relat Disord; 2018 Oct; 25():112-121. PubMed ID: 30059895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]